-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ligand Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Ligand Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$9.48M, a 37.7% increase year-over-year.
- Ligand Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $75.1M, a 0.48% decline year-over-year.
- Ligand Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2023 was $51.7M, a 56.8% increase from 2022.
- Ligand Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was $33M.
- Ligand Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$31.6M, a 12.6% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)